Medical and Pharmaceutical Industries

Surmet Corporation is a world leader in surface metallurgy, engineered coatings and advanced materials solutions.

Spectral Sciences, Inc. is a research and development company dedicated to solving problems from concept to prototype. SSI has developed many industry standard computer codes as well as unique instrument prototypes to help in the development of cutting-edge technologies for its clients.

Skyworks Solutions, Inc. is an innovator of high reliability analog and mixed signal semiconductors. Leveraging core technologies, Skyworks offers diverse standard and custom linear products supporting automotive, broadband, cellular infrastructure, energy management, industrial, medical, military and mobile handset applications.

Siemens Healthcare Diagnostics offers a broad portfolio of performance-driven diagnostics solutions that provide more effective ways to assist in the diagnosis, monitoring and management of disease. Our products and services offer the right balance of science, technology and practicality across the healthcare continuum to provide healthcare professionals with the vital information they need to deliver better, more personalized healthcare to patients around the globe.

Through our Shire Human Genetic Therapies business, we pursue opportunities on behalf of patients and families facing such rare diseases as Fabry disease, Hunter syndrome, Gaucher disease, hereditary angioedema, and metachromatic leukodystrophy—patients whose very lives often hinge on the discovery and delivery of extraordinary medicines.

World Leader in developing high performance composities from textiles, nonwovens, and films via lamination and coating technologies.

Sunovion Pharmaceuticals Inc. is a research-based pharmaceutical company dedicated to discovering, developing and commercializing scientifically advanced therapeutic products that are focused on helping patients suffering from central nervous system and respiratory disorders, as well as other illnesses.

Sanofi-aventis U.S. is part of a leading global pharmaceutical company that discovers, develops, produces and markets innovative therapies that enhance people’s lives.

Repligen Corporation is a biopharmaceutical company focused on the development of novel therapeutics for neurological disorders. A number of drug development programs are currently being conducted to evaluate our drug candidates in diseases such as bipolar disorder and Friedreich's ataxia.

Pulpdent's manufacturing includes a sophisticated chemical production laboratory and automated machine shop. To facilitate processing raw materials into finished goods, Pulpdent has developed complex systems and controls to ensure quality and customer satisfaction.